Related Experiment Video
Updated: Aug 3, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Soft tissue tuberculosis: a series of 11 cases
M P Puttick1, H B Stein, R M Chan
1Department of Medicine, University of British Columbia, British Columbia Centre for Disease Control (TB Division), Vancouver, Canada.
Tuberculosis (TB) of the soft tissues presents as unexplained swelling and pain, especially in foreign-born individuals or those who are immunosuppressed. Early diagnosis and treatment with multiple drugs are crucial for managing this condition.
Area of Science:
- Infectious Diseases
- Rheumatology
- Orthopedics
Background:
- Soft tissue tuberculosis (TB) is a rare manifestation of Mycobacterium tuberculosis infection.
- Clinical presentation can be nonspecific, mimicking other inflammatory or neoplastic conditions.
- Risk factors include immunosuppression, foreign birth in endemic areas, and prior TB exposure.
Observation:
- A retrospective review identified 11 cases of soft tissue TB between 1988 and 1994.
- Patients often presented with swelling and pain, with a mean duration of 4.4 months.
- Commonly associated conditions included collagen vascular disorders, kidney transplant, and immunosuppressive therapy.
Findings:
- Foreign birth was a significant factor in most cases.
- Trauma and history of previous TB were noted in some patients.
- Coexisting active TB at other sites was present in half of the cases.
- Treatment involved debridement/drainage and multi-drug therapy for 6-12 months, with frequent medication intolerance.
Implications:
- Soft tissue TB should be considered in the differential diagnosis of unexplained soft tissue masses, particularly in at-risk populations.
- Prompt diagnosis and appropriate anti-TB therapy are essential for favorable outcomes.
- Awareness of potential relapses and medication intolerance is important for patient management.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis